8-KLeadership Changes

CORNING INC /NY 8-K Report, Executive Changes (Feb 4, 2009)

Filed February 4, 2009For Securities:GLW

Summary

Corning Incorporated announced on February 4, 2009, a change to its Board of Directors. Dr. Mark S. Wrighton has been elected to the Board, effective immediately. This appointment follows a recommendation from the Board Nominating and Corporate Governance Committee and a thorough review confirming no related party transactions with the company, as per SEC regulations. This addition to the board brings new expertise and is a standard governance update. Investors should note that this event does not involve any immediate financial implications or operational changes for Corning, but it reflects ongoing board composition management and adherence to corporate governance best practices. The company continues to focus on its core business operations.

Key Highlights

  • 1Corning Incorporated elected Dr. Mark S. Wrighton to its Board of Directors.
  • 2The election was effective February 4, 2009.
  • 3The Board Nominating and Corporate Governance Committee recommended Dr. Wrighton.
  • 4Corning's Board of Directors formally elected Dr. Wrighton.
  • 5It was confirmed that Dr. Wrighton has no related party transactions with Corning.
  • 6This is an Item 5.02 filing, concerning director appointments.

Frequently Asked Questions

This 8-K filing announces the election of a new director, Dr. Mark S. Wrighton, to Corning Incorporated's Board of Directors and serves to inform the public and shareholders of this governance change.

Based on the filing, there are no immediate financial implications disclosed. The report specifically states that Dr. Wrighton has no related party transactions with the company, indicating a standard, non-financial appointment.

Dr. Wrighton was nominated by the Board Nominating and Corporate Governance Committee and elected by the Board. While specific reasons for his selection beyond his suitability as a director are not detailed in this filing, such appointments typically aim to bring diverse expertise and experience to the board.

Related party transactions refer to business dealings between the company and individuals or entities that have close ties to the company, such as directors, executives, or their family members. The disclosure that Dr. Wrighton has no such transactions ensures transparency and adherence to corporate governance standards, preventing potential conflicts of interest.